Insider Trading30 Jun 2026, 08:50 pm

Novartis India Closes Trading Window for Q1 FY27

AI Summary

Novartis India Limited has announced the closure of its trading window for designated persons and their relatives. This closure is effective from July 1, 2026, and will remain in effect until 48 hours after the company intimates its unaudited financial results for the quarter ended June 30, 2026, to the stock exchange. The decision aligns with SEBI regulations concerning insider trading.

Key Highlights

Trading window closure effective July 1, 2026.
Applies to designated persons and immediate relatives.
Closure is for the quarter ended June 30, 2026.
Aims to comply with SEBI insider trading regulations.
Window reopens 48 hours post financial results disclosure.

View BSE Filing

NOVARTIND

Pharmaceuticals

NOVARTIS INDIA LTD.

Price Impact